Actively Recruiting
Quantitative Analysis of Upper Extremity Functional Movement in Patients With Duchenne Muscular Dystrophy
Led by Seoul National University Hospital · Updated on 2025-06-13
30
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are analyzing changes in upper arm movement over time in children and young adults with Duchenne Muscular Dystrophy (DMD). This observational study focuses on improving evaluation methods for upper limb function in non-ambulatory DMD patients by using clinical tests and advanced video analysis. Thirty participants will be studied to better understand functional changes and support future care. Participants will be assessed at three visits: baseline, 6 months, and 12 months. At each visit, clinical assessments including the Performance of the Upper Limb module 2.0 (PUL 2.0), Brooke Scale, and grip strength tests will be performed. These evaluations will be combined with computer vision video analysis and machine learning to provide detailed movement data. During the study, participants will undergo clinical exams and video recordings to track upper limb function. The main measure is the PUL 2.0 score over time, with secondary measures including Brooke Scale scores and grip strength. Safety monitoring is in place, patient data confidentiality is maintained, and compensation is available if any adverse effects occur. The total participation lasts about one year with three assessment visits.
CONDITIONS
Brief Title
ML-Based Multi-Sensor Fall Risk Screening in DMD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD)
- Age over 10 and under 30 years
- Brooke Scale score between 2 and 5
- Manual muscle test grade below 3 for shoulder abduction muscles
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Brooke Scale score of 1 or 6
- Cognitive impairments that significantly limit participation in assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants undergo clinical assessments and video analysis to evaluate upper limb function using the Performance of the Upper Limb, Brooke Scale, and grip strength tests.
3 visits at baseline, 6 months, and 12 months
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, Jongno, South Korea, 03080
Actively Recruiting
Research Team
J
JungHyun Kim, prof
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here